Cargando…

Perspectives on long-acting growth hormone therapy in children and adults

Growth hormone therapy with daily injections of recombinant human growth hormone has been available since 1985, and is shown to be safe and effective treatment for short stature in children and for adult growth hormone deficiency. In an effort to produce a product that would improve patient adherenc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lal, Rayhan A., Hoffman, Andrew R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Endocrinologia e Metabologia 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237337/ https://www.ncbi.nlm.nih.gov/pubmed/31939485 http://dx.doi.org/10.20945/2359-3997000000190

Ejemplares similares

Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations
por: Christiansen, Jens Sandahl, et al.
Publicado: (2016)

Long‐acting growth hormone in 2022
por: Steiner, Margaret, et al.
Publicado: (2023)

Usefulness and Potential Pitfalls of Long-Acting Growth Hormone Analogs
por: Yuen, Kevin C. J., et al.
Publicado: (2021)

Corrigendum: Usefulness and Potential Pitfalls of Long-Acting Growth Hormone Analogues
por: Yuen, Kevin C. J., et al.
Publicado: (2021)

Growth Hormone Research Society perspective on biomarkers of GH action in children and adults
por: Johannsson, Gudmundur, et al.
Publicado: (2018)

First Clinical Study on Long-Acting Growth Hormone Therapy in Children with Turner Sydrome
por: Gao, Xinying, et al.
Publicado: (2022)

Effects of different doses of long-acting growth hormone in treating children with growth hormone deficiency
por: Xia, Wei, et al.
Publicado: (2023)

Correction: First Clinical Study on Long-Acting Growth Hormone Therapy in Children with Turner Sydrome
por: Gao, Xinying, et al.
Publicado: (2023)

Guidance for the treatment of adult growth hormone deficiency with somapacitan, a long-acting growth hormone preparation
por: Bidlingmaier, Martin, et al.
Publicado: (2022)

Long acting growth hormone (LAGH), an update
por: Grillo, Margaret Steiner, et al.
Publicado: (2023)

Corrigendum: Guidance for the treatment of adult growth hormone deficiency with somapacitan, a long-acting growth hormone preparation
por: Bidlingmaier, Martin, et al.
Publicado: (2023)

Effect of Weekly Long-Acting Growth Hormone Replacement Therapy Compared to Daily Growth Hormone on Children With Short Stature: A Meta-Analysis
por: Ma, Liyan, et al.
Publicado: (2021)

Adult Growth Hormone Deficiency: Diagnostic and Treatment Journeys From the Patients’ Perspective
por: Hoffman, Andrew R, et al.
Publicado: (2022)

Retraction: Effect of weekly long-acting growth hormone replacement therapy compared to daily growth hormone on children with short stature: a meta-analysis
por: Office, Frontiers Editorial
Publicado: (2023)

The Use of IGF-I to Monitor Long-Acting Growth Hormone Therapy—Timing is an Art…
por: Bidlingmaier, Martin, et al.
Publicado: (2021)

A phase 2 trial of long-acting TransCon growth hormone in adult GH deficiency
por: Höybye, Charlotte, et al.
Publicado: (2017)

Growth hormone receptor agonists and antagonists: From protein expression and purification to long‐acting formulations
por: Wang, Yue, et al.
Publicado: (2023)

Long-term Response to Recombinant Human Growth Hormone Therapy in Indian Children with Growth Hormone Deficiency
por: Gahlot, Monita, et al.
Publicado: (2019)

Thyroid function in children with growth hormone deficiency during long-term growth hormone replacement therapy
por: Witkowska-Sędek, Ewelina, et al.
Publicado: (2018)

The Rationale for Growth Hormone Therapy in Children with Short Stature
por: Deodati, Annalisa, et al.
Publicado: (2017)

Growth Hormone Therapy in Adults with Prader-Willi Syndrome
por: Vogt, Karen S., et al.
Publicado: (2015)

Long-acting PEGylated recombinant human growth hormone (Jintrolong) for children with growth hormone deficiency: phase II and phase III multicenter, randomized studies
por: Luo, Xiaoping, et al.
Publicado: (2017)

Patient perspectives in the development and use of long-acting antipsychotics in schizophrenia: focus on olanzapine long-acting injection
por: Citrome, Leslie
Publicado: (2009)

Motivation for and adherence to growth hormone replacement therapy in adults with hypopituitarism: the patients‘ perspective
por: Kreitschmann-Andermahr, Ilonka, et al.
Publicado: (2020)

What do we do now that the long-acting growth hormone is here?
por: Miller, Bradley S.
Publicado: (2022)

Russell Silver syndrome: a perspective on growth and the influence of growth hormone therapy
por: Mascarenhas, J. V., et al.
Publicado: (2012)

Thyroid Hormone Changes Related to Growth Hormone Therapy in Growth Hormone Deficient Patients
por: Kucharska, Anna Małgorzata, et al.
Publicado: (2021)

MOD-4023, a long-acting carboxy-terminal peptide-modified human growth hormone: results of a Phase 2 study in growth hormone-deficient adults
por: Strasburger, Christian J, et al.
Publicado: (2016)

Growth hormone treatment in non-growth hormone-deficient children
por: Loche, Sandro, et al.
Publicado: (2014)

The variability of responses to growth hormone therapy in children with short stature
por: Savage, Martin O., et al.
Publicado: (2012)

Counseling for Growth Hormone Therapy
por: Kalra, Sanjay, et al.
Publicado: (2021)

Hormones Act in Concert to Direct Plant Growth
Publicado: (2004)

Tissue Distribution and Receptor Activation by Somapacitan, a Long Acting Growth Hormone Derivative
por: Petersen, Maj, et al.
Publicado: (2020)

Achieving Optimal Short- and Long-term Responses to Paediatric Growth Hormone Therapy
por: Wit, Jan M., et al.
Publicado: (2019)

Patient and Health Care Provider Perspectives on Long Acting Injectable Antipsychotics in Schizophrenia and the Introduction of Olanzapine Long-Acting Injection
por: Wehring, Heidi J., et al.
Publicado: (2011)

Treatment with Growth Hormone for Adults with Growth Hormone Deficiency Syndrome: Benefits and Risks
por: Díez, Juan J., et al.
Publicado: (2018)

ODP329 Long-term Effect of Daily Growth Hormone Replacement Therapy on Glucose Tolerance in Adult growth Hormone Deficiency
por: Bando, Hironori, et al.
Publicado: (2022)

Efficacy of growth hormone therapy in adults with childhood-onset growth hormone deficiency
por: Kim, Ja Hye, et al.
Publicado: (2014)

A Long-Acting Human Growth Hormone With Delayed Clearance (VRS-317): Results of a Double-Blind, Placebo-Controlled, Single Ascending Dose Study in Growth Hormone–Deficient Adults
por: Yuen, Kevin C. J., et al.
Publicado: (2013)

Pharmacokinetics of olanzapine long-acting injection: the clinical perspective
por: Heres, Stephan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tm32eprcl5pph4ge6gpv5oimv6